LINDSAY BRUNSWICK: Open Payments
NPI 1952173403 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143 in 7 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $258 · 2025 $143
Food & beverage: $143
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| PFIZER INC. | 1 | $25 |
| TAIHO ONCOLOGY, INC. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: KISQALI, PYLARIFY, XTANDI, LONSURF, OJJAARA, OPDIVO.
Industry payments across KY — which companies pay providers there.
